Posted 10/10/2017 2:28 AM (GMT 0)
Thanks. nyc lawyer, yes, Dr. Mychalczak said, “We have done 800,” from which I inferred all of MSKCC.
JNF, that’s a great result.
This is a very tough decision as all of you know, and I’m grateful for your thoughts.
One of my interpretive challenges is that the RO said “high risk” and wanted me to consider a clinical trial designed for “very high risk” people, for which he said I was borderline eligible, whereas at the surgeon’s office they said “intermediate risk.” The more I read the more I seem between intermediate but unfavorable and high risk.
Facts: 1. clinical stage at repeated DREs was T2a but MRI found probable EPE.
2. Both Hopkins and MSKCC said G4+3, with 5/12 cores positive, all on right side.
3. PSA was 6.5 in July 2011, then 8 in July 2013 Dx BPH, then 23.8 in July 2017 right after prostate-manipulating exercise on X-country skiier, then 20.44 in September 2017 seven weeks after biopsy. Unfortunately not repeated before biopsy. Surgeon thought there would be a residual effect of the biopsy.
Very approximate calculations based on postings here would suggest that main tumor at G7 and 3.6 cc would account for approximately 10.8 of the PSA, and the other 40cc of prostate, if all normal, would be 2.7. If there is BPH it would add something. Since there were leukocytes in urinalysis and high white blood cell count in blood work, and I did not do antibiotics because DRE made biopsy the next step, there could be some prostatitis, although neither CT nor MRI said so. Whatever the rest is, and however much it is, will come, as Tall Allen said, from cancer too small to show up on scans. Or maybe this is over-analyzed.
Why surgery? It offers more definitive diagnosis, my wife and I can accept the SE, and all the docs say I seem healthy enough. Dr. Touijer has done prostatectomies on men older than I with good outcomes.
I wish there was a way to know for sure what to do.